Valvular & structural heart disease

Outcomes of Early vs Delayed Aortic Valve Replacement: Analysis of the EARLY Transcatheter Aortic Valve Replacement (TAVR) Valve Implant Population

JACC Cardiovasc IntervPublished Secondary analysis of the EARLY TAVR randomised trial

Primary result · Death, stroke or HF hospitalizationResult — go to the resultAdjusted hazard ratio 0.61 95% CI 0.38–0.99

Authors' conclusion

Among patients with asymptomatic, severe AS, delayed AVR with AVS is associated with higher rates of death, stroke, or heart failure hospitalization compared with early TAVR

Study context

Population
Patients with asymptomatic, severe aortic stenosis (AS) undergoing valve implant, 75 sites75 sites
Participants
444 vs 388
Comparison
Early TAVR vs delayed aortic valve replacement (AVR) after clinical surveillance
  • Early TAVRn = 444reference
  • Delayed AVRn = 388
Primary endpoint
Composite of:
  • Death
  • Stroke
  • HF hospitalization
Follow-up
2 years postprocedure
Methodological detailsmulticentre, valve implant population, 97.6% of early TAVR patients (444 of 455) underwent the index procedure; 87.0% of clinical surveillance (CS) patients (388 of 446) underwent delayed AVR through 5 years
  • Multicentre
  • Valve implant population
  • 97.6% of early TAVR patients (444 of 455) underwent the index procedure; 87.0% of CS patients (388 of 446) underwent delayed AVR through 5 years

Primary result

Death, stroke or HF hospitalization

Adjusted hazard ratio

0.61

95% CI 0.38–0.99

P = 0.045

Early TAVR vs Delayed AVR
adjusted HR 0.61 (95% CI 0.38–0.99); P = 0.045

As reported in the abstract

Further findings

OutcomeAdjusted HR (95% CI)P value
Primary composite by presentation: delayed AVR with acute valve syndrome (AVS) vs early TAVR — Delayed AVR with AVS vs Early TAVR2.12 (1.19–3.78)P = 0.01
Primary composite by presentation: delayed AVR with acute valve syndrome (AVS) vs early TAVR — Delayed AVR with AVS vs Early TAVR · stroke2.92 (1.26–6.76)P = 0.01
  • Primary composite by presentation: delayed AVR with acute valve syndrome (AVS) vs early TAVR: 39.2% of delayed AVR presented with AVS, 58.5% with progressive valve syndrome
  • Primary composite by presentation: delayed AVR with acute valve syndrome (AVS) vs early TAVR: median time to delayed AVR 11.1 months

Original publication

Outcomes of Early vs Delayed Aortic Valve Replacement: Analysis of the EARLY TAVR Valve Implant Population. JACC Cardiovasc Interv. Published 24 November 2025. doi:10.1016/j.jcin.2025.09.029

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.